Stock Quote

How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS

By Kate Morgan

SOURCE: Johnson & Johnson

SUMMARY:

On the 40th anniversary of what would become the first AIDS diagnosis, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.

DESCRIPTION:

Forty years ago, in June 1981, a mysterious disease emerged in California and New York. It would soon become one of the most well-known—and urgent—health challenges of our time.

Today, there are some 38 million people in the world living with human immunodeficiency virus (HIV). Each year, 1.7 million more are newly infected with the virus.

Continue reading here

Tweet me: On the 40th anniversary of what would become the first AIDS diagnosis, @JNJNews looks at the groundbreaking strides the company has made—and continues to make. https://bit.ly/2XMObVH

KEYWORDS: NYSE:JNJ, johnson & johnson, HIV/AIDS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.